Erratum for Randell et al., "Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole".
Date
2025-09
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Volume 68, no. 4, e01533-23, 2024, https://doi.org/10.1128/aac.01533-23. Page 6, Table 1, row 7: “7” should read “15.7.” This typographical error for the Hill parameter estimate did not impact any modeling code or analysis, and the results, conclusions, and clinical relevance of the study are unchanged.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Randell, Rachel L, Stephen J Balevic, Rachel G Greenberg, Michael Cohen-Wolkowiez, Elizabeth J Thompson, Saranya Venkatachalam, Michael J Smith, Catherine Bendel, et al. (2025). Erratum for Randell et al., "Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole". Antimicrobial agents and chemotherapy, 69(9). p. e0097225. 10.1128/aac.00972-25 Retrieved from https://hdl.handle.net/10161/33581.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Stephen Joseph Balevic
I am an Adult and Pediatric Rheumatologist and care for patients with a wide variety of autoimmune and rheumatic diseases, including: systemic lupus, rheumatoid arthritis, juvenile arthritis, vasculitis, and sarcoidosis, among others. I have a special interest in using musculoskeletal ultrasound to optimize diagnosis and treatment decisions at the bedside.
I am also a clinical researcher at the Duke Clinical Research Institute (DCRI). My research interests are in clinical trials and precision medicine through population pharmacokinetic/pharmacodynamic modeling. I obtained my PhD in Pharmaceutical Sciences from the UNC Eshelman School of Pharmacy. I serve as the principal investigator on several grants studying hydroxychloroquine and azathioprine pharmacokinetics and exposure-response in lupus, as well as principal investigator or co-investigator for several clinical trials at the DCRI. Additionally, I am an Assistant Scientific Director for the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry- the largest registry of children with rheumatic diseases in North America.
Rachel Gottron Greenberg
Rachel G. Greenberg, MD, MB, MHS is a neonatologist and Professor of Pediatrics at Duke University Medical Center and Duke Clinical Research Institute. Dr. Greenberg’s research focuses on improving safety and efficacy of drugs in infants and children, particularly through her efforts as a Principal Investigator and Steering Committee Chair for the NICHD-funded Pediatric Trials Network. She is also alternate PI of the North Carolina clinical Center for the Neonatal Research Network and PI of the NICHD-funded HEAL KIDS Pain Resource and Data Center. In addition, she has been principal investigator of multiple trials funded by the U.S. Food and Drug Administration, Centers for Disease Control, and National Institutes of Health.
Michael Cohen-Wolkowiez
Pediatric and adult clinical pharmacology and clinical trials.
Elizabeth Thompson
Chi Hornik
Chi Hornik is the Director of Heart Center Research and the Director of Critical Care Medicine Research in the Department of Pediatrics. She is an Associate Professor in the Duke School of Medicine and a member of the Duke Clinical Research Institute (DCRI). She serves as Principal Investigator (PI) of Duke as a site for numerous studies and as clinical coordinating center PI of multi-center trials through the DCRI. As a clinical specialist in neonatal and pediatric critical care, she is dedicated to advancing drug and device development. She ensures that the research encompasses patients who are representative of the disease or condition being studied. Her commitment is to advance health outcomes for all children, striving for equity in clinical research.
Christoph Paul Vincent Hornik
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.